After PCI and short-term DAPT, P2Y12 inhibitors alone vs. ongoing DAPT reduce major bleeding; CV events do not differ.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33075262.
- Also identified by DOI 10.7326/ACPJ202010200-042.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malik AH, Yandrapalli S, Shetty SS, et al. <b>Meta-analysis of dual antiplatelet therapy versus monotherapy with P2Y12 inhibitors in patients after percutaneous coronary intervention.</b> Am J Cardiol. 2020;127:25-9. 32389351.
Medical subject headings
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors